{
    "2020-06-30": [
        [
            {
                "time": "",
                "original_text": "直追药明康德，泰格一天豪掷9亿投向新医药，康龙化成、凯莱英一群CXO扎堆进入",
                "features": {
                    "keywords": [
                        "药明康德",
                        "泰格",
                        "康龙化成",
                        "凯莱英",
                        "CXO",
                        "新医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "小摩减持康龙化成(03759)约168.88万股，涉资约1.26亿港元 减持股份",
                "features": {
                    "keywords": [
                        "小摩",
                        "减持",
                        "康龙化成",
                        "港股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成现4笔大宗交易 共成交14,948.52万元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "CXO泡沫浴：分享创新药红利的最好方式",
                "features": {
                    "keywords": [
                        "CXO",
                        "创新药",
                        "泡沫"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}